Open Access Peer-reviewed Review

Progress of hollow materials in diagnosis of COVID-19

Main Article Content

Abid Hussain
Sonia Shabbir
Muhammad Faizan corresponding author
Muhammad Ali Tajwar


Since the outbreak of COVID-19 in Wuhan, China, it has dramatically changed the global geopolitics, economics, and even society standard norms. The present world scenario is changed regarding business, traveling, and education. Rapid global dissemination and the high mortality rate of coronaviruses are the greatest challenges for drug developers. It will be moving forward toward the identification and treatment of emerging coronaviruses with the aid of nanotechnology. The COVID-19 pandemic raised the question of researchers’ capability to manage this dilemma in a short period. In the present review, we described how hallow material could be developed as a pro-drug that shows an excellent therapeutic effect. Hollow nanoparticles that exploration of antiviral or diagnostic agents against emerging coronaviruses. Hollow nanomaterials in vaccine development are essential because hollow nanocomposites are suitable for mimicking viral structures and antigen delivery. A biosensor that generates a signal from a transducer for comparing and analyzing biological conjugates such as cell receptors, antibodies, RNA, DNA, and nucleic acids. Different biosensors, such as graphene-based biosensors, nanoplasmonic sensor chips, nanomaterial biosensors, electrochemical biosensors, dual modality biosensors, and optical biosensors, have several advantages, characteristics, and a wide range of applications, most remarkably in medical treatment and are used for monitoring and diagnosis. This review focuses on modern experimental studies to identify intelligent and innovative bio/nanomaterials and matrices for developing targeted and controlled drug release systems, nanosensors and nanovaccines to combat pathogenic viruses.

COVID-19, nanoparticles, hollow materials, diagnostic agents, nano/bio-sensors, pathogenic viruses

Article Details

How to Cite
Hussain, A., Shabbir, S., Faizan, M., & Tajwar, M. A. (2022). Progress of hollow materials in diagnosis of COVID-19. Chemical Reports, 4(1), 218-243.


  1. Joshi VG, Vikas D, DimpalT, et al. Multiple antigenic peptide (MAP): a synthetic peptide dendrimer for diagnostic, antiviral and vaccine strategies for emerging and re-emerging viral diseases. Indian Journal of Virology, 2013, 24(3): 312-320.
  2. Abbasi BH, Nazir M, Muhammad W, et al. A Comparative Evaluation of the Antiproliferative Activity against HepG2 Liver Carcinoma Cells of Plant-Derived Silver Nanoparticles from Basil Extracts with Contrasting Anthocyanin Contents. Biomolecules, 2019, 9(8): 320.
  3. Gheibi Hayat SM and Darroudi M. Nanovaccine: A novel approach in immunization. Journal of Cellular Physiology, 2019, 234(8): 12530-12536.
  4. Yang X, Ma C, Zhao C, Zhang Y, et al. Preparation and mechanism of hydroxyapatite hollow microspheres with different surface charge by biomimetic method. Journal of Materials Science: Materials in Medicine, 2020, 31(5): 1-9.
  5. Nikaeen G, Abbaszadeh S and Yousefinejad S. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses. Nanomedicine, 2020, 15(15): 1501-1512.
  6. Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. Journal of Nanobiotechnology, 2018, 16(1): 1-33.
  7. Ding J, Venkatesan R, Zhai Z, et al. Micro-and nanoparticles-based immunoregulation of macrophages for tissue repair and regeneration. Colloids and Surfaces B: Biointerfaces, 2020, 192: 111075.
  8. Ogden N, Abdelmalik P and Pulliam J. Emerging Infections: Emerging infectious diseases: prediction and detection. Canada Communicable Disease Report, 2017, 43(10): 206.
  9. Cojocaru FD, Botezat D, Gardikiotis I, et al. Nanomaterials designed for antiviral drug delivery transport across biological barriers. Pharmaceutics, 2020, 12(2): 171.
  10. Kanellos T, Sylvester ID, Howard CR, et al. DNA is as effective as protein at inducing antibody in fish. Vaccine, 1999, 17(7-8): 965-972.
  11. Shin MD. COVID-19 vaccine development and a potential nanomaterial path forward. Nature nanotechnology, 2020, 15(8): 646-655.
  12. Singh A, misra R, Mohanty C, et al. Applications of nanotechnology in vaccine delivery. International Journal of Green Nanotechnology: Biomedicine, 2010, 2(1): 25-45.
  13. Vijayan V, mohapatra A, Uthaman S, et al. Recent advances in nanovaccines using biomimetic immunomodulatory materials. Pharmaceutics, 2019, 11(10): 534.
  14. Lin LC, Huang C, Yao B, et al. Viromimetic STING agonist loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus. Advanced functional materials, 2019, 29(28): 1807616.
  15. Jiang J, Liu Y, Wu C, et al. Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells. Drug Development & Industrial Pharmacy, 2017, 43(8): 1304-1313.
  16. Hasanzadeh A, Alamdaran m, Ahmedi S, et al. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. Journal of Controlled Release, 2021, 336: 354-374.
  17. Ranjbar, S, Fatahi Y and Atyabi F. The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19? Journal of Drug Delivery Science and Technology, 2021, 67: 102899.
  18. Lu R, zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet, 2020, 395(10224): 565-574.
  19. Organization WH. WHO-convened global study of origins of SARS-CoV-2: China part, 2021.
  20. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England journal of medicine, 2020, 382: 1199-1207.
  21. Wrapp D, Wang N, Corbett K, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 2020, 367(6483): 1260-1263.
  22. Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS-CoV-2. Nature medicine, 2020, 26(4): 450-452.
  23. Wan Y, Shang G, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of virology, 2020, 94(7): e00127-20.
  24. Zhang J, Xie B and Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain, Behavior, and Immunity, 2020, 87: 59-73.
  25. Letko M, Marzi A and Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol, 2020, 5: 562-9.
  26. Wan Y, Shang G, Graham R, et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of Virology, 2020, 94(7): 1-9.
  27. Walls AC, park YJ, tortorici MJ, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 2020, 181(2): 281-292.
  28. Berry JD, Jone S, Derbot MA, et al. Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. Journal of virological methods, 2004, 120(1): 87-96.
  29. Chacón-Torres JC, Reinoso C, Dainela G, et al. Optimized and scalable synthesis of magnetic nanoparticles for RNA extraction in response to developing countries' needs in the detection and control of SARS-CoV-2. Scientific reports, 2020, 10(1): 1-10.
  30. Gorshkov K, Susumu K, Chen J, et al. Quantum dot-conjugated sars-cov-2 spike pseudo-virions enable tracking of angiotensin converting enzyme 2 binding and endocytosis. ACS nano, 2020, 14(9): 12234-12247.
  31. Samson R, Navale GR and Dharne MS. Biosensors: Frontiers in rapid detection of COVID-19. Biotech, 2020, 10(9): 1-9.
  32. Wang B, Li R, Lu Z, et al. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY), 2020, 12(7): 6049.
  33. Winichakoon P, Chaiwarith R, Salee P, et al. Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19. Journal of clinical microbiology, 2020, 58(5): e00297-20.
  34. Pan Y, Li X, Yang G, et al. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. Journal of Infection, 2020, 81(1): e28-e32.
  35. Lin D, Liu L, Zhang M, et al. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak. European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39(12): 2271-2277.
  36. Lipsitch M, Swerdlow DL and Finelli L. Defining the epidemiology of Covid-19-studies needed. New England journal of medicine, 2020, 382(13): 1194-1196.
  37. Okba NM, Müller MA, Li W, et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerging infectious diseases, 2020, 26(7): 1478-1488.
  38. Shen Z, Xiao J, Kang L, et al. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clinical infectious diseases, 2020, 71(15): 713-720.
  39. Moitra P, Alafeef M, Dighe K, et al. Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles. ACS nano, 2020, 14(6): 7617-7627.
  40. Yan S, Sun H, Bu X ,et al. New strategy for COVID-19: an evolutionary role for RGD motif in SARS-CoV-2 and potential inhibitors for virus infection. Frontiers in Pharmacology, 2020, 11: 912.
  41. Smith YR, Bhattacharyya D, Mohanty SK, et al. Anodic Functionalization of Titania Nanotube Arrays for the Electrochemical Detection of Tuberculosis Biomarker Vapors. Journal of The Electrochemical Society, 2016, 163(3): 83-89.
  42. Hematian A , Sadeghifard N, Mohebi R, et al. Traditional and modern cell culture in virus diagnosis. Osong public health and research perspectives, 2016, 7(2): 77-82.
  43. Azmi A, Azman AA, Ibrahim S, et al. Techniques in Advancing the Capabilities of Various Nitrate Detection Methods: A Review. International Journal on Smart Sensing & Intelligent Systems, 2017, 10(2): 1-39.
  44. Vadlamani BS, Uppal T, Verma SC, et al. Functionalized TiO2 Nanotube-Based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2. Sensors, 2020, 20(20): 5871.
  45. Kumar N, Shetti NP, Jagannath, et al. Electrochemical sensors for the detection of SARS-CoV-2 virus. Chemical Engineering Journal, 2022, 430: 132966.
  46. Farzin L, Shamsipur M, Samandari L, et al. HIV biosensors for early diagnosis of infection: The intertwine of nanotechnology with sensing strategies. Talanta, 2020, 206: 120201.
  47. Seo G, Lee G, Kim MJ, et al. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS nano, 2020, 14(4): 5135-5142.
  48. Ahmadivand A, Gerislioglu B, Ramezani Z, et al. Functionalized terahertz plasmonic metasensors: Femtomolar-level detection of SARS-CoV-2 spike proteins. Biosensors and Bioelectronics, 2021, 177(42): 112971.
  49. Azzi L, Carcano G, Gianfagna F, et al. Saliva is a reliable tool to detect SARS-CoV-2. Journal of Infection, 2020, 81(1): e45-e50.
  50. Kevadiya BD, Machhi J, Herskovitz J, et al. Diagnostics for SARS-CoV-2 infections. Nature Materials, 2021, 20: 593-605.
  51. Fruncillo S, Su X, Liu H, et al. Lithographic Processes for the Scalable Fabrication of Micro-and Nanostructures for Biochips and Biosensors. ACS sensors, 2021, 6(6): 2002-2024.
  52. Shan B, Broza YY, Li W, et al. Multiplexed nanomaterial-based sensor array for detection of COVID-19 in exhaled breath. ACS nano, 2020, 14(9): 12125-12132.
  53. Cheng N, Chen D, Lou B, et al. A biosensing method for the direct serological detection of liver diseases by integrating a SERS-based sensor and a CNN classifier. Biosensors and Bioelectronics, 2021, 186: 113246.
  54. Abduljalil JM, Laboratory diagnosis of SARS-CoV-2: available approaches and limitations. New microbes and new infections, 2020: 100713.
  55. Kevadiya BD, Machhi J, Herskovitz J, et al. Diagnostics for SARS-CoV-2 infections. Nature materials, 2021, 20(5): 593-605.
  56. Shrotri M, Schalkwyk M, Post N, et al. T cell response to SARS-CoV-2 infection in humans: A systematic review. PLoS One, 2021, 16(1): e0245532.
  57. Katrin Z, Weyh M, Krueger C, et al. Rapid detection of SARS-CoV-2 by pulse-controlled amplification (PCA). medRxiv, 2020, 36: 100713. 2020.07.29.20154104.
  58. Infantino M, Damiani A, Gobbi FL, et al. Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives. Isr Med Assoc J, 2020, 22(4): 203-210.
  59. Dheda K., Ruhwald M, Theron G, et al. Point of care diagnosis of tuberculosis: Past, present and future. Respirology, 2013, 18(2): 217-232.
  60. Shen M, Zhou Y, Yeet J, et al. Recent advances and perspectives of nucleic acid detection for coronavirus. Journal of Pharmaceutical Analysis, 2020, 10(2): 97-101.
  61. Qin L, Yang Y, Cao Q, et al. A predictive model and scoring system combining clinical and CT characteristics for the diagnosis of COVID-19. European radiology, 2020, 30(12): 6797-6807.
  62. Xu Y, Yang Y, Cao Q, et al. Current approaches in laboratory testing for SARS-CoV-2. 2020. 100: 7-9.
  63. D'Cruz RJ, Currier AW and Sampson VB. Laboratory testing methods for novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Frontiers in cell and developmental biology, 2020, 8: 468.
  64. Qi J, Lai X, Wang J, et al. Multi-shelled hollow micro-/nanostructures. Chemical Society Reviews, 2015, 44(19): 6749-6773.
  65. Long L, Liu X, Chen L, et al. A hollow CuO x/NiO y nanocomposite for amperometric and non-enzymatic sensing of glucose and hydrogen peroxide. Microchimica Acta, 2019, 186(2): 74.
  66. He G, Tian L, Cai, y et al. Sensitive nonenzymatic electrochemical glucose detection based on hollow porous NiO. Nanoscale research letters, 2018, 13(1): 1-10.
  67. Abunahla H, Mohammad B, Alazzam A, et al. MOMSense: metal-oxide-metal elementary glucose sensor. Scientific reports, 2019, 9(1): 1-10.
  68. Zhang J, Sun Y, Li X, et al. Fabrication of porous NiMn 2 O 4 nanosheet arrays on nickel foam as an advanced sensor material for non-enzymatic glucose detection. Scientific reports, 2019, 9(1): 1-13.
  69. Qian J, Wang Y, Pan J, et al. Non-enzymatic glucose sensor based on ZnO-CeO2 whiskers. Materials Chemistry and Physics, 2020, 239: 122051.
  70. Gandhi M, Yokoe DS and Havlir DV. Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19. New England Journal of Medicine, 2020, 382(22): 2158-2160.
  71. Muti M, Sharma S, Erdem A, et al. Electrochemical monitoring of nucleic acid hybridization by single‐use graphene oxide‐based sensor. Electroanalysis, 2011, 23(1): 272-279.
  72. Bi S, Zhao T and Luo B. A graphene oxide platform for the assay of biomolecules based on chemiluminescence resonance energy transfer. Chemical Communications, 2012, 48(1): 106-108.
  73. Liu F, Xiang G, Zhang L ,et al. A novel label free long non-coding RNA electrochemical biosensor based on green L-cysteine electrodeposition and Au-Rh hollow nanospheres as tags. RSC advances, 2015, 5(64): 51990-51999.
  74. Liu X, Cheng Z, Fan H, et al. Electrochemical detection of avian influenza virus H5N1 gene sequence using a DNA aptamer immobilized onto a hybrid nanomaterial-modified electrode. Electrochimica Acta, 2011, 56(18): 6266-6270.
  75. Low SS, Tan MTT, Loh HS, et al. Facile hydrothermal growth graphene/ZnO nanocomposite for development of enhanced biosensor. Analytica chimica acta, 2016, 903: 131-141.
  76. Łoczechin A, Séron K, Barras A, et al. Functional carbon quantum dots as medical countermeasures to human coronavirus. ACS applied materials & interfaces, 2019, 11(46): 42964-42974.
  77. Mao X, Liu S, Yang C, et al. Colorimetric detection of hepatitis B virus (HBV) DNA based on DNA-templated copper nanoclusters. Analytica chimica acta, 2016, 909: 101-108.
  78. Chen X, Liu S, Yang C, et al. An ultrasensitive DNA biosensor based on enzyme-catalyzed deposition of cupric hexacyanoferrate nanoparticles. Biosensors and Bioelectronics, 2010, 25(6): 1420-1426.
  79. Tsang NM, Chang KP, Lin SY, et al. Detection of Epstein‐Barr Virus-Derived Latent Membrane Protein‐1 Gene in Various Head and Neck Cancers: Is It Specific for Nasopharyngeal Carcinoma? The Laryngoscope, 2003, 113(6): 1050-1054.
  80. Riccò R, Meneghello A and Enrichi F. Signal enhancement in DNA microarray using dye doped silica nanoparticles: application to human papilloma virus (HPV) detection. Biosensors and Bioelectronics, 2011, 26(5): 2761-2765.
  81. Tsang MK, Ye WW, Wang G, et al. Ultrasensitive detection of Ebola virus oligonucleotide based on upconversion nanoprobe/nanoporous membrane system. Acs Nano, 2016, 10(1): 598-605.
  82. Chen CC, Lai ZL, Wang GJ, et al. Polymerase chain reaction-free detection of hepatitis B virus DNA using a nanostructured impedance biosensor. Biosensors and Bioelectronics, 2016, 77: 603-608.
  83. Hyeon T, Piao Y and Park YI. Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same. Google Patents, 2016.
  84. Mashhadizadeh MH and Talemi RP. A highly sensitive and selective hepatitis B DNA biosensor using gold nanoparticle electrodeposition on an Au electrode and mercaptobenzaldehyde. Analytical Methods, 2014, 6(22): 8956-8964.
  85. Ma C, Xie G, Zhang W, et al. Label-free sandwich type of immunosensor for hepatitis C virus core antigen based on the use of gold nanoparticles on a nanostructured metal oxide surface. Microchimica Acta, 2012, 178(3): 331-340.
  86. Sabela M, Balme S, Bechelany M, et al. A review of gold and silver nanoparticle‐based colorimetric sensing assays. Advanced Engineering Materials, 2017, 19(12): 1700270.
  87. Yu KH, Beam AL and Kohane ISJN. Artificial intelligence in healthcare. Nature Biomedical Engineering, 2018, 2(10): 719-731.
  88. Castillo HL, Acuña MB, Rojas Ac, et al. Biosensors for the Detection of Bacterial and Viral Clinical Pathogens. Sensors, 2020, 20(23): 6926.
  89. Rosén T, Hsiao BS and Söderberg LD. Elucidating the opportunities and challenges for nanocellulose spinning. Advanced Materials, 2021, 33(28): 2001238.
  90. Yockell-Lelièvre, H, Bukar N, Toulouse JL, et al. Naked-eye nanobiosensor for therapeutic drug monitoring of methotrexate. Analyst, 2016, 141(2): 697-703.
  91. Jianrong C, Yuqing M, Nongyue H. et al. Nanotechnology and biosensors. Biotechnology advances, 2004, 22(7): 505-518.
  92. Socorro-Leránoz AB, Santano D, Villar ID, et al. Trends in the design of wavelength-based optical fibre biosensors (2008-2018). Biosensors and Bioelectronics, 2019, 1: 100015.
  93. Mishra RK and Rajakumari R. Chapter 1 - Nanobiosensors for Biomedical Application: Present and Future Prospects, in Characterization and Biology of Nanomaterials for Drug Delivery, S.S. Mohapatra, et al. Editors. 2019, Elsevier. p. 1-23.
  94. Fu Z, Lu YC and Lai JJ. Recent Advances in Biosensors for Nucleic Acid and Exosome Detection. Chonnam Medical Journal, 2019, 55(2): 86-98.
  95. Veselinovic J, AlMashtoub S, Nagella S, et al. Interplay of effective surface area, mass transport, and electrochemical features in nanoporous nucleic acid sensors. Analytical chemistry, 2020, 92(15): 10751-10758.
  96. Park CS, Lee C and Kwon OSJP. Conducting polymer based nanobiosensors. 2016. 8(7): 249.
  97. Chamorro-Garcia A and Merkoçi AJN. Nanobiosensors in diagnostics. Nanobiosensors in diagnostics, 2016, 3: 1849543516663574.
  98. Harvey JD, Baker HA, Ortiz MV, et al. HIV detection via a carbon nanotube RNA sensor. ACS Sensors, 2019, 4(5): 1236-1244.
  99. Lin Z, Wu G, Zhao L, et al. Carbon nanomaterial-based biosensors: a review of design and applications. IEEE Nanotechnology Magazine, 2019, 13(5): 4-14.
  100. Pirzada M and Altintas Z. Nanomaterials for Healthcare Biosensing Applications. Sensors, 2019, 19(23): 5311.
  101. Shetti NP, Bukkitgar SD, Reddy KR,et al. ZnO-based nanostructured electrodes for electrochemical sensors and biosensors in biomedical applications. Biosensors and Bioelectronics, 2019, 141: 111417.
  102. Cevik M, Tate M, Lloyd O, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. The lancet microbe, 2021, 2(1): e13-e22.
  103. Shetti NP, Bukkitgar SD, Reddy KR, et al. Nanostructured silver doped TiO2/CNTs hybrid as an efficient electrochemical sensor for detection of anti-inflammatory drug, cetirizine. Microchemical Journal, 2019, 150: 104124.
  104. Shetti NP, Bukkitgar SD, Reddy KR, et al. Sensors based on ruthenium-doped TiO2 nanoparticles loaded into multi-walled carbon nanotubes for the detection of flufenamic acid and mefenamic acid. Analytica chimica acta, 2019, 1051: 58-72.
  105. Kumar S., Bukkitgar SD, Singh S, et al. Electrochemical Sensors and Biosensors Based on Graphene Functionalized with Metal Oxide Nanostructures for Healthcare Applications. ChemistrySelect, 2019, 4(18): 5322-5337.
  106. Yoon S and Kim HK. Cost-effective stretchable Ag nanoparticles electrodes fabrication by screen printing for wearable strain sensors. Surface and Coatings Technology, 2020, 384: 125308.
  107. Guo W, Shim K and Kim YT. Ag layer deposited on Zn by physical vapor deposition with enhanced CO selectivity for electrochemical CO2 reduction. Applied Surface Science, 2020, 526: 146651.
  108. Shetti NP, Malode SJ, Bukkitgar SD, et al. Electro-oxidation and determination of nimesulide at nanosilica modified sensor. Materials Science for Energy Technologies, 2019, 2(3): 396-400.
  109. Teng Z, Li W, Tang Y, et al. Mesoporous organosilica hollow nanoparticles: synthesis and applications. Advanced Materials, 2019, 31(38): 1707612.
  110. Tamayo-Velasco Á, Peñarrubia-Ponce MJ, Alveriz Fj, et al. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection. Journal of personalized medicine, 2021, 11(7): 681.
  111. Lee T, Park SY, Jang H, et al. Fabrication of electrochemical biosensor consisted of multi-functional DNA structure/porous au nanoparticle for avian influenza virus (H5N1) in chicken serum. Materials Science and Engineering: C, 2019, 99: 511-519.
  112. Shariati M, Ghorbani M, Sasanpour P et al. An ultrasensitive label free human papilloma virus DNA biosensor using gold nanotubes based on nanoporous polycarbonate in electrical alignment. Analytica Chimica Acta, 2019, 1048: 31-41.
  113. Wang J. Electrochemical biosensing based on noble metal nanoparticles. Microchimica Acta, 2012, 177(3): 245-270.
  114. Zhang Y, Li B, Wei X, et al. Amplified electrochemical antibiotic aptasensing based on electrochemically deposited AuNPs coordinated with PEI-functionalized Fe-based metal-organic framework. Microchimica Acta, 2021, 188(8): 1-11.
  115. Masud MK, Umer M, Hossain MSA,et al. Nanoarchitecture frameworks for electrochemical miRNA detection. Trends in biochemical sciences, 2019, 44(5): 433-452.
  116. Rezaei B, Ghani M, Shoushtari AM, et al. Electrochemical biosensors based on nanofibres for cardiac biomarker detection: A comprehensive review. Biosensors and Bioelectronics, 2016, 78: 513-523.
  117. Mahari S, Roberts A, Shahdeo D, et al. eCovSens-ultrasensitive novel in-house built printed circuit board based electrochemical device for rapid detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2. BioRxiv, 2020.
  118. Bhattacharyya D, Smith YR, Mohanty Sk, et al. Titania nanotube array sensor for electrochemical detection of four predominate tuberculosis volatile biomarkers. Journal of The Electrochemical Society, 2016, 163(6): B206.
  119. Smith YR, Bhattacharyya D, Mohanty Sk, et al. Anodic functionalization of titania nanotube arrays for the electrochemical detection of tuberculosis biomarker vapors. Journal of the Electrochemical Society, 2015, 163(3): B83.
  120. Kumar S, Bukkitgar SD, Singh S, et al. Electrochemical sensors and biosensors based on graphene functionalized with metal oxide nanostructures for healthcare applications. ChemistrySelect, 2019, 4(18): 5322-5337.
  121. Bukkitgar S and Shetti N. Fabrication of a TiO 2 and clay nanoparticle composite electrode as a sensor. Analytical methods, 2017, 9(30): 4387-4393.
  122. Bukkitgar SD, Shetti NP and Kulkarni RM. Construction of nanoparticles composite sensor for atorvastatin and its determination in pharmaceutical and urine samples. Sensors and Actuators B: Chemical, 2018, 255: 1462-1470.
  123. Shikandar D, Shetti NP, Kulkarni RM, et al. Silver-doped titania modified carbon electrode for electrochemical studies of furantril. ECS Journal of Solid State Science and Technology, 2018, 7(7): Q3215.
  124. Mishra A, Basu S, Shetti NP, et al. Photocatalysis of Graphene and Carbon Nitride-Based Functional Carbon Quantum Dots. Nanoscale Materials in Water Purification, 2019, 759-781.
  125. Mishra A, Basu S, Shetti NP, et al. Carbon cloth-based hybrid materials as flexible electrochemical supercapacitors. ChemElectroChem, 2019, 6(23): 5771-5786.
  126. Singh L, Kruger HG, Maguire GEM, et al. The role of nanotechnology in the treatment of viral infections. Therapeutic advances in infectious disease, 2017, 4(4): 105-131.
  127. Cho IH, Kim DH and Park S. Electrochemical biosensors: Perspective on functional nanomaterials for on-site analysis. Biomaterials research, 2020, 24(1): 1-12.
  128. Zhao F, Bai Y, Cao L, et al. New electrochemical DNA sensor based on nanoflowers of Cu3 (PO4) 2-BSA-GO for hepatitis B virus DNA detection. Journal of Electroanalytical Chemistry, 2020, 867: 114184.
  129. Khristunova E, Barek J, Kratochvil B, et al. Electrochemical immunoassay for the detection of antibodies to tick-borne encephalitis virus by using various types of bioconjugates based on silver nanoparticles. Bioelectrochemistry, 2020, 135: 107576.
  130. Kwon J, Lee Y, Lee T, et al. Aptamer-based field-effect transistor for detection of avian influenza virus in chicken serum. Analytical chemistry, 2020, 92(7): 5524-5531.
  131. Kaushik A, Yndart A, Kumar S, et al. A sensitive electrochemical immunosensor for label-free detection of Zika-virus protein. Scientific reports, 2018, 8(1): 1-5.
  132. Bandodkar AJ, Imani S, Nunez-Flores R, et al. Re-usable electrochemical glucose sensors integrated into a smartphone platform. Biosensors and Bioelectronics, 2018, 101: 181-187.
  133. Walgama C, Nguyen MP, Boatner LM, et al. Hybrid paper and 3D-printed microfluidic device for electrochemical detection of Ag nanoparticle labels. Lab on a Chip, 2020, 20(9): 1648-1657.
  134. McArdle H, Nguyen MP, Boatner LM, et al. Triangular silver nanoplates: Properties and ultrasensitive detection of miRNA. Electrochemistry Communications, 2017, 79: 23-27.
  135. Sheridan, C. Fast, portable tests come online to curb coronavirus pandemic. Nat Biotechnol, 2020, 38(5): 515-8.
  136. Li X, Scida K and Crooks RM. Detection of hepatitis B virus DNA with a paper electrochemical sensor. Analytical chemistry, 2015, 87(17): 9009-9015.
  137. Zhang X, Tanner P, Graff A, et al. Mimicking the cell membrane with block copolymer membranes. Journal of polymer science part A: polymer chemistry, 2012, 50(12): 2293-2318.
  138. de Eguilaz MR, Cumba LR and Forster RJ. Electrochemical detection of viruses and antibodies: A mini review. Electrochemistry communications, 2020, 116: 106762.
  139. Dai Y and Liu CC. Recent Advances on Electrochemical Biosensing Strategies toward Universal Point-of-Care Systems. Angewandte Chemie International Edition, 2019, 58(36): 12355-12368.
  140. Chen JHK, Yip CCY, Poon RWS, et al. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2. Emerging microbes & infections, 2020, 9(1): 1356-1359.
  141. Choi JR. Development of point-of-care biosensors for COVID-19. Frontiers in chemistry, 2020, 8: 517.
  142. Lee JH, Park SJ and Choi JW. Electrical property of graphene and its application to electrochemical biosensing. Nanomaterials, 2019, 9(2): 297.
  143. Chan C, Shi J, Fan Y, et al. A microfluidic flow-through chip integrated with reduced graphene oxide transistor for influenza virus gene detection. Sensors and Actuators B: Chemical, 2017, 251: 927-933.
  144. OnoT, Oe T, Kanai Y, et al. Glycan-functionalized graphene-FETs toward selective detection of human-infectious avian influenza virus. Japanese Journal of Applied Physics, 2017, 56(3): 030302.
  145. Seo G, Lee G, Kim MJ, et al. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor. ACS Nano, 2020, 14(4): 5135-5142.
  146. Iravani, S. Nano-and biosensors for the detection of SARS-CoV-2: challenges and opportunities. Materials Advances, 2020, 1(9): 3092-3103.
  147. Liu J, Chen X, Wang Q, et al. Ultrasensitive Monolayer MoS(2) Field-Effect Transistor Based DNA Sensors for Screening of Down Syndrome. Nano Lett, 2019, 19(3): 1437-1444.
  148. Janissen R, Sahoo PK, Santos CA, et al. InP Nanowire Biosensor with Tailored Biofunctionalization: Ultrasensitive and Highly Selective Disease Biomarker Detection. Nano Lett, 2017, 17(10): 5938-5949.
  149. Layqah LA and Eissa S. An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes. Microchimica Acta, 2019, 186(4): 1-10.
  150. Wen F, He T, Liu H, et al. Advances in chemical sensing technology for enabling the next-generation self-sustainable integrated wearable system in the IoT era. Nano Energy, 2020, 78: 105155.
  151. Ryvolová M, Macka M and Preisler J. Portable capillary-based (non-chip) capillary electrophoresis. TrAC Trends in Analytical Chemistry, 2010, 29(4): 339-353.
  152. Ganganboina AB , Chowdhury AD, Khoris IM, et al. Hollow magnetic-fluorescent nanoparticles for dual-modality virus detection. Biosensors and Bioelectronics, 2020, 170: 112680.
  153. Chuon TT, Pallaoro A, Chaves Ca, et al. Dual-reporter SERS-based biomolecular assay with reduced false-positive signals. Proceedings of the National Academy of Sciences, 2017, 114(34): 9056-9061.
  154. Park J, Jeong Y, Kim J, et al. Biopsy needle integrated with multi-modal physical/chemical sensor array. Biosensors and Bioelectronics, 2020, 148: 111822.
  155. Wu Z, Zeng T, Guo Wj ,et al. Digital Single Virus Immunoassay for Ultrasensitive Multiplex Avian Influenza Virus Detection Based on Fluorescent Magnetic Multifunctional Nanospheres. ACS Applied Materials & Interfaces, 2019, 11(6): 5762-5770.
  156. Shrivastava S, Trung TQ and Lee NE. Recent progress, challenges, and prospects of fully integrated mobile and wearable point-of-care testing systems for self-testing. Chemical Society Reviews, 2020, 49(6): 1812-1866.
  157. Guerrero-Martínez A, Pérez-Juste J and Liz-Marzán LM. Recent progress on silica coating of nanoparticles and related nanomaterials. Advanced materials, 2010, 22(11): 1182-1195.
  158. Dutta CA, Ganganboina AB, Tsai Y, et al. Multifunctional GQDs-Concanavalin A@Fe(3)O(4) nanocomposites for cancer cells detection and targeted drug delivery. Anal Chim Acta, 2018, 1027: 109-120.
  159. Song L, Wang Z, Liu J, et al. Tumor-Targeted DNA Bipyramid for in Vivo Dual-Modality Imaging. ACS Applied Bio Materials, 2020, 3(5): 2854-2860.
  160. Wang R, Lin J, Lassiter K, et al. Evaluation study of a portable impedance biosensor for detection of avian influenza virus. Journal of Virological Methods, 2011, 178(1-2): 52-58.
  161. Lake RJ, Yang Z, Zhang JJ, et al. DNAzymes as activity-based sensors for metal ions: recent applications, demonstrated advantages, current challenges, and future directions. Accounts of chemical research, 2019, 52(12): 3275-3286.
  162. Medina CB, Mehrotra P, Arandjelov S, et al. Metabolites released from apoptotic cells act as tissue messengers. Nature, 2020, 580(7801): 130-135.
  163. Takemura K, Satoh J, Boonyakida J, et al. Electrochemical detection of white spot syndrome virus with a silicone rubber disposable electrode composed of graphene quantum dots and gold nanoparticle-embedded polyaniline nanowires. Journal of nanobiotechnology, 2020, 18(1): 1-12.
  164. Nasrin F, Chowdhury AD, Takemura K, et al. Fluorometric virus detection platform using quantum dots-gold nanocomposites optimizing the linker length variation. Analytica chimica acta, 2020, 1109: 148-157.
  165. Chowdhury AD, Takemura k, Li TC, et al. Electrical pulse-induced electrochemical biosensor for hepatitis E virus detection. Nature communications, 2019,10(1): 1-12.
  166. ZhouH, Zhang j, Li B, et al. Dual-Mode SERS and Electrochemical Detection of miRNA Based on Popcorn-like Gold Nanofilms and Toehold-Mediated Strand Displacement Amplification Reaction. Analytical chemistry, 2021, 93(15): 6120-6127.
  167. Sathiyamoorthy K, Mohankumar VK and Murukeshan VM. Real time monitoring of fluorescent particles in micro-channels by high resolution dual modality probe imaging. Optics and Photonics Journal, 2011, 1(4): 197-203.
  168. Ali MA, Tabassum S, Wang Q, et al. Integrated dual-modality microfluidic sensor for biomarker detection using lithographic plasmonic crystal. Lab on a Chip, 2018, 18(5): 803-817.
  169. Zhuang J, Yin J, Lv S,et al. Advanced ``lab-on-a-chip" to detect viruses-Current challenges and future perspectives. Biosensors and Bioelectronics, 2020, 163: 112291.
  170. Qiu G, Gai Z, Tao Y, et al. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection. ACS Nano, 2020, 14(5): 5268-5277.
  171. Damborský P, Švitel J and Katrlík J. Optical biosensors. Essays in biochemistry, 2016, 60(1): 91-100.
  172. Takemura K. Surface plasmon resonance (SPR)-and localized SPR (LSPR)-based virus sensing systems: Optical vibration of nano-and micro-metallic materials for the development of next-generation virus detection technology. Biosensors, 2021, 11(8): 250.
  173. Nag P, Sadani K and Mukherji S. Optical fiber sensors for rapid screening of COVID-19. Transactions of the Indian National Academy of Engineering, 2020, 5(2): 233-236.
  174. Socorro-Leránoz AB, Santano D, Villar ID, et al. Trends in the design of wavelength-based optical fibre biosensors (2008-2018). Biosensors and Bioelectronics, 2019, 1: 100015.
  175. Roh C and Jo SK. Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots-conjugated RNA aptamer on chip. Journal of Chemical Technology & Biotechnology, 2011, 86(12): 1475-1479.
  176. Ye H, Liu Y, Zhan L, et al. Signal amplification and quantification on lateral flow assays by laser excitation of plasmonic nanomaterials. Theranostics, 2020, 10(10): 4359-4373.
  177. Lung J, Lin YS, Yang YH, et al. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. Journal of Medical Virology, 2020, 92(6): 693-697.
  178. Yu R, Chen L, Lan R, et al. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. International Journal of Antimicrobial Agents, 2020, 56(2): 106012.
  179. Jauffred L, Samadi A, Klingberg H, et al. Plasmonic Heating of Nanostructures. Chemical Reviews, 2019, 119(13): 8087-8130.
  180. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 2020, 25(3): 2000045.
  181. Khalid K, Tan X, Mohd ZHF, et al. Advanced in developmental organic and inorganic nanomaterial: a review. Bioengineered, 2020, 11(1): 328-355.
  182. Bruinink A, Wang J and Wick P. Effect of particle agglomeration in nanotoxicology. Archives of toxicology, 2015, 89(5): 659-675.
  183. Cao J, Sun T and Grattan KT. Gold nanorod-based localized surface plasmon resonance biosensors: A review. Sensors and actuators B: Chemical, 2014, 195: 332-351.
  184. Zhang L, Mazouzi Y, Salmain M, et al. Antibody-gold nanoparticle bioconjugates for biosensors: synthesis, characterization and selected applications. Biosensors and Bioelectronics, 2020, 165: 112370.
  185. Qiu G, Yue Y, Tang J, et al. Total bioaerosol detection by a Succinimidyl-Ester-functionalized Plasmonic biosensor to reveal different characteristics at three locations in Switzerland. Environmental science & technology, 2020, 54(3): 1353-1362.
  186. Turunc E, Binzet R, Gumus I, et al. Green synthesis of silver and palladium nanoparticles using Lithodora hispidula (Sm.) Griseb.(Boraginaceae) and application to the electrocatalytic reduction of hydrogen peroxide. Materials Chemistry and Physics, 2017, 202: 310-319.
  187. Baghayer M, Alinezhad H, Tarahomi M, et al. A non-enzymatic hydrogen peroxide sensor based on dendrimer functionalized magnetic graphene oxide decorated with palladium nanoparticles. Applied Surface Science, 2019, 478: 87-93.
  188. Petryayeva E and Krull UJ. Localized surface plasmon resonance: Nanostructures, bioassays and biosensing-A review. Analytica chimica acta, 2011, 706(1): 8-24.
  189. Funari R, Chu KY and Shen AQ. Detection of antibodies against SARS-CoV-2 spike protein by gold nanospikes in an opto-microfluidic chip. Biosensors and Bioelectronics, 2020, 169: 112578.
  190. Xia Y, Chen Y, Tang Y, et al. Smartphone-Based Point-of-Care Microfluidic Platform Fabricated with a ZnO Nanorod Template for Colorimetric Virus Detection. ACS Sensors, 2019, 4(12): 3298-3307.
  191. Verma N, Badhe Y, Gupta R, et al. Interactions of Peptide Coated Gold Nanoparticles with Spike Protein of the SARS-CoV-2: A Basis for Design of a Simple and Rapid Detection Tool. 2020.
  192. Hussei HA, Hassan RYA, Chino M, et al. Point-of-care diagnostics of COVID-19: from current work to future perspectives. Sensors, 2020, 20(15): 4289.
  193. Pan Y, Zhang D, Yang P, et al. Viral load of SARS-CoV-2 in clinical samples. The Lancet Infectious Diseases, 2020, 20(4): 411-412.
  194. Chen Z, Zhang Z, Zhai X, et al. Rapid and sensitive detection of anti-SARS-CoV-2 IgG, using lanthanide-doped nanoparticles-based lateral flow immunoassay. Analytical chemistry, 2020, 92(10): 7226-7231.
  195. Li Z, Yi Y, Luo X,et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. Journal of medical virology, 2020, 92(9): 1518-1524.
  196. Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature, 2020, 581(7807): 221-224.
  197. Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive care medicine, 2020, 46(4): 586-590.
  198. Barnes CO, Jette CA, Abernathy ME, et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature, 2020, 588(7839): 682-687.
  199. Thakur A, Sathyamurthy R, Ramalingam V, et al. A case study of SARS-CoV-2 transmission behavior in severe air-polluted city (Delhi, India) and potential usage of graphene based materials for filtering the air-pollutants and controlling/monitoring the COVID-19 pandemic. Environmental Science: Processes & Impacts, 2021.
  200. Celina MC, Martinez E, Omana MA, et al. Extended use of face masks during the COVID-19 pandemic-Thermal conditioning and spray-on surface disinfection. Polymer Degradation and Stability, 2020, 179: 109251.
  201. Rai NK, Ashok A and Akondi BR. Consequences of chemical impact of disinfectants: safe preventive measures against COVID-19. Critical Reviews in Toxicology, 2020, 50(6): 513-520.
  202. Egorova KS, Gordeev EG and Ananikov VP. Biological activity of ionic liquids and their application in pharmaceutics and medicine. Chemical Reviews, 2017, 117(10): 7132-7189.
  203. Klyachko NL, Manickam DS, Brynskikh AM, et al. Cross-linked antioxidant nanozymes for improved delivery to CNS. Nanomedicine Nanotechnology Biology & Medicine, 2012, 8(1): 119-129.
  204. Yi X, Devika SM, Anna B, et al. Agile delivery of protein therapeutics to CNS. Journal of Controlled Release, 2014, 190: 637-663.